Abstract:BackgroundDue to excellent performance in antitumor, antioxidation, antihypertension, antiatherosclerotic and antidepressant activities, crocetin, naturally exists in Crocus sativus L., has great potential applications in medical and food fields. Microbial production of crocetin has received increasing concern in recent years. However, only a patent from EVOVA Inc. and a report from Lou et al. have illustrated the feasibility of microbial biosynthesis of crocetin, but there was no specific titer data reported so far. Saccharomyces cerevisiae is generally regarded as food safety and productive host, and manipulation of key enzymes is critical to balance metabolic flux, consequently improve output. Therefore, to promote crocetin production in S. cerevisiae, all the key enzymes, such as CrtZ, CCD and ALD should be engineered combinatorially.ResultsBy introduction of heterologous CrtZ and CCD in existing β-carotene producing strain, crocetin biosynthesis was achieved successfully in S. cerevisiae. Compared to culturing at 30 °C, the crocetin production was improved to 223 μg/L at 20 °C. Moreover, an optimal CrtZ/CCD combination and a titer of 351 μg/L crocetin were obtained by combinatorial screening of CrtZs from nine species and four CCDs from Crocus. Then through screening of heterologous ALDs from Bixa orellana (Bix_ALD) and Synechocystis sp. PCC6803 (Syn_ALD) as well as endogenous ALD6, the crocetin titer was further enhanced by 1.8-folds after incorporating Syn_ALD. Finally a highest reported titer of 1219 μg/L at shake flask level was achieved by overexpression of CCD2 and Syn_ALD. Eventually, through fed-batch fermentation, the production of crocetin in 5-L bioreactor reached to 6278 μg/L, which is the highest crocetin titer reported in eukaryotic cell.ConclusionsSaccharomyces cerevisiae was engineered to achieve crocetin production in this study. Through combinatorial manipulation of three key enzymes CrtZ, CCD and ALD in terms of screening enzymes sources and regulating protein expression level (reaction temperature and copy number), crocetin titer was stepwise improved by 129.4-fold (from 9.42 to 1219 μg/L) as compared to the starting strain. The highest crocetin titer (6278 μg/L) reported in microbes was achieved in 5-L bioreactors. This study provides a good insight into key enzyme manipulation involved in serial reactions for microbial overproduction of desired compounds with complex structure.

Complete microbial synthesis of crocetin and crocins from glycerol in Escherichia coli

Construction of Escherichia Coli Cell Factories for Crocin Biosynthesis

Heterologous biosynthesis and manipulation of crocetin in Saccharomyces cerevisiae

Metabolic Engineering of Crocin Biosynthesis in Nicotiana Species

Research progress on the pharmacological activity, biosynthetic pathways, and biosynthesis of crocins

Crocetin Overproduction in Engineered Saccharomyces cerevisiae via Tuning Key Enzymes Coupled With Precursor Engineering

Construction of a high-efficiency GjCCD4a mutant and its application for de novo biosynthesis of five crocins in Escherichia coli

Gardenia carotenoid cleavage dioxygenase 4a is an efficient tool for biotechnological production of crocins in green and non-green plant tissues

Selective transformation of crocin-1 to crocetin-glucosyl esters by β-glucosidase (Lf18920) from Leifsonia sp. ZF2019: Insights from molecular docking and point mutations

Crocin Synthesis Mechanism in Crocus Sativus

Crocetin: A Systematic Review

Selective Biosynthesis of Retinol in S. Cerevisiae.

Transcriptome Analysis Reveals Novel Enzymes for Apo-Carotenoid Biosynthesis in Saffron and Allows Construction of a Pathway for Crocetin Synthesis in Yeast

Biosynthesis of Crocin in a Solid-Liquid Two-Step Cell Culture

Construction of a Stable and Temperature-Responsive Yeast Cell Factory for Crocetin Biosynthesis Using CRISPR-Cas9

Progress on Molecular Breeding and Metabolic Engineering of Biosynthesis Pathways of C(30), C(35), C(40), C(45), C(50) Carotenoids.

Metabolic engineering of Bacillus subtilis toward the efficient and stable production of C30-carotenoids

Progress on Molecular Breeding and Metabolic Engineering of Biosynthesis Pathways of C30, C35, C40, C45, C50 Carotenoids

Redesign and reconstruction of a steviol-biosynthetic pathway for enhanced production of steviol in Escherichia coli

New findings in the metabolism of the saffron apocarotenoids, crocins and crocetin, by the human gut microbiota

Metabolic engineering of Escherichia coli for the biosynthesis of α-copaene from glucose